- Home
- GAIN vs CMPX Comparison
GAIN vs CMPX Comparison
Compare GAIN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- CMPX
- Stock Information
- Founded
- GAIN 2005
- CMPX 2014
- Country
- GAIN United States
- CMPX United States
- Employees
- GAIN N/A
- CMPX N/A
- Industry
- GAIN Finance: Consumer Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- GAIN Finance
- CMPX Health Care
- Exchange
- GAIN Nasdaq
- CMPX Nasdaq
- Market Cap
- GAIN 497.3M
- CMPX 408.6M
- IPO Year
- GAIN 2005
- CMPX N/A
- Fundamental
- Price
- GAIN $13.38
- CMPX $1.59
- Analyst Decision
- GAIN Hold
- CMPX Strong Buy
- Analyst Count
- GAIN 2
- CMPX 7
- Target Price
- GAIN $13.75
- CMPX $12.43
- AVG Volume (30 Days)
- GAIN 114.8K
- CMPX 850.8K
- Earning Date
- GAIN 05-07-2025
- CMPX 05-12-2025
- Dividend Yield
- GAIN 7.18%
- CMPX N/A
- EPS Growth
- GAIN N/A
- CMPX N/A
- EPS
- GAIN 1.92
- CMPX N/A
- Revenue
- GAIN $89,176,000.00
- CMPX $850,000.00
- Revenue This Year
- GAIN $5.92
- CMPX $47.65
- Revenue Next Year
- GAIN $10.25
- CMPX $3,909.48
- P/E Ratio
- GAIN $7.10
- CMPX N/A
- Revenue Growth
- GAIN 6.78
- CMPX N/A
- 52 Week Low
- GAIN $12.46
- CMPX $0.77
- 52 Week High
- GAIN $14.85
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- GAIN 47.29
- CMPX 24.62
- Support Level
- GAIN $13.52
- CMPX $2.18
- Resistance Level
- GAIN $13.68
- CMPX $2.17
- Average True Range (ATR)
- GAIN 0.18
- CMPX 0.19
- MACD
- GAIN 0.01
- CMPX -0.06
- Stochastic Oscillator
- GAIN 53.28
- CMPX 19.48
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.